1. a. As provided in subsection c. of this section, the Division of Consumer Affairs in the Department of Law and Public Safety shall develop a prescription drug pricing disclosure website in order to make prescription drug price information available to New Jersey practitioners. The website shall have a dedicated link that is prominently displayed on the division’s home page.

b. The website shall include, at a minimum, the following data elements, separated by therapeutic category:

(1) name of the product;

(2) whether the drug is brand name or generic;

(3) drug strength;

(4) per-unit wholesale acquisition cost of the drug, provided to the division by pharmaceutical manufacturing companies pursuant to section 2 of P.L.2019, c.404 (C. 24:6N-1); and

(5) any disclaimers deemed appropriate by the division that are not inconsistent with State or federal law or regulations .

c. The division shall actively seek grant funds to implement the provisions of this section, and implementation shall be contingent upon the division obtaining sufficient grant funds for the development, operation, and continued maintenance of the prescription drug pricing disclosure website. The division shall have the authority to enter into a contract for the administration of the division’s responsibilities pursuant to this section. The division shall establish the disclosure website no later than six months after it receives grant funds in an amount sufficient to develop and operate the website as provided in this subsection.

d. Each State board and other entity that, under Title 45 of the Revised Statutes, regulates individuals with prescriptive authority in New Jersey shall advise the licensees of the board or entity at least once annually of the opportunity to access the prescription drug pricing disclosure website.

L.2019, c.404, s.1.